- Home
- ALGS vs BLIV Comparison
ALGS vs BLIV Comparison
Compare ALGS & BLIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALGS
- BLIV
- Stock Information
- Founded
- ALGS 2018
- BLIV 2014
- Country
- ALGS United States
- BLIV Singapore
- Employees
- ALGS N/A
- BLIV N/A
- Industry
- ALGS Biotechnology: Pharmaceutical Preparations
- BLIV
- Sector
- ALGS Health Care
- BLIV
- Exchange
- ALGS Nasdaq
- BLIV NYSE
- Market Cap
- ALGS 36.0M
- BLIV 39.8M
- IPO Year
- ALGS 2020
- BLIV 2025
- Fundamental
- Price
- ALGS $7.20
- BLIV $4.01
- Analyst Decision
- ALGS Strong Buy
- BLIV
- Analyst Count
- ALGS 1
- BLIV 0
- Target Price
- ALGS $70.00
- BLIV N/A
- AVG Volume (30 Days)
- ALGS 156.2K
- BLIV 127.9K
- Earning Date
- ALGS 08-05-2025
- BLIV 01-01-0001
- Dividend Yield
- ALGS N/A
- BLIV N/A
- EPS Growth
- ALGS N/A
- BLIV N/A
- EPS
- ALGS N/A
- BLIV N/A
- Revenue
- ALGS $3,270,000.00
- BLIV $1,355,200.00
- Revenue This Year
- ALGS N/A
- BLIV N/A
- Revenue Next Year
- ALGS N/A
- BLIV N/A
- P/E Ratio
- ALGS N/A
- BLIV N/A
- Revenue Growth
- ALGS N/A
- BLIV N/A
- 52 Week Low
- ALGS $3.76
- BLIV $2.69
- 52 Week High
- ALGS $46.80
- BLIV $6.40
- Technical
- Relative Strength Index (RSI)
- ALGS 62.71
- BLIV N/A
- Support Level
- ALGS $5.47
- BLIV N/A
- Resistance Level
- ALGS $6.12
- BLIV N/A
- Average True Range (ATR)
- ALGS 0.59
- BLIV 0.00
- MACD
- ALGS 0.21
- BLIV 0.00
- Stochastic Oscillator
- ALGS 88.92
- BLIV 0.00
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.